| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |